510(k) Report

510(k) · Cleared

Recalled · Class II · 2022

Immulite/Immulite 1000 Total Testosterone and Immulite 2000 Total Testosterone

K032881510(k) SpecialCleared Oct 10, 200325-day reviewClass I21 CFR 862.1680Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diagnostic Products Corp. · CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

Cleared on Oct 10, 2003 as substantially equivalent to K022603 (Diagnostic Products Corp., 2002) and 1 other predicate after a 25-day review. Its family tree reaches back 2 generations to 1991. It has been recalled 2 times.

Decided
Oct 10, 2003
Review
25 days
Class
Class I
Product code
CDZ
Recalls
2
Predicates
2

Its longest line of descent runs back 2 generations to K905215 (1991). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1996: 1 other ancestorK905215 · Immulite (TM) Automated Immunoassay Analyzer · Cirrus Diagnostics, Inc. · 1991K022603 · Immulite 1000 Automated Immunoassay Analyzer · Diagnostic Products Corp. · 2002 · recalled1990199520002005
  1. Root · 2 generations backK905215 Immulite (TM) Automated Immunoassay AnalyzerCirrus Diagnostics, Inc. · 1991
  2. 1 generation backK022603 Immulite 1000 Automated Immunoassay AnalyzerDiagnostic Products Corp. · 2002 · Recalled
  3. This deviceK032881 Immulite/Immulite 1000 Total Testosterone and Immulite 2000 Total…Diagnostic Products Corp. · 2003
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K905215Immulite (TM) Automated Immunoassay AnalyzerCirrus Diagnostics, Inc.1991—
−1K022603Immulite 1000 Automated Immunoassay AnalyzerDiagnostic Products Corp.20022
0 (this device)K032881Immulite/Immulite 1000 Total Testosterone and Immulite 2000 Total TestosteroneDiagnostic Products Corp.2003—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
FIG. 1 — Lineage of K032881, 1991–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CDZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CDZ device

  1. #1 K252728 IDS-iSYS Total Testosteronescore 11.8 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K022603Immulite 1000 Automated Immunoassay Analyzer
Summary page 2
…egistration Number is 2017 183 Substantially Equivalent Predicate Device: IMMULITE/IMMULITE 1000 Total Testosterone (K022603) IMMULITE 2000 Total Testosterone (K955870) Description of Device: IMMULITE/IMMUL…
Diagnostic Products Corp.20022
*K955870Immulite Total Testosterone
Summary page 2
…IMMULITE/IMMULITE 1000 Total Testosterone (K022603) IMMULITE 2000 Total Testosterone (K955870) Description of Device: IMMULITE/IMMULITE 1000 Total Testosterone is a solid-phas…
Diagnostic Products Corp.1996—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 25, 2022Class IIZ-0355-2023Process controlConfirmed an average positive bias of 40% for testosterone concentrations of approximately 660 ng/dL (22.9 nmol/L) and above with the IMMULITE/IMMULITE 1000 Total Testosterone Assay when compared to the IMMULITE 2000/IMMULITE 2000 XPi…
Jan 3, 2006Not classifiedZ-0528-06OtherThe reagent for this kit lot (L2KTW 2,6 126) was manufactured with a raw material that can carryover and interfere with DPC Kit IMMULITE 2000 Estradiol (L2KE2) causing a false elevation in the observed estradiol concentration.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 2 companies; a new generation was cleared every 11.6 years on median.
  • 1 of the 3 ancestors has a recall of any class.

How does its category compare?

All CDZ devices

CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CDZ

2in 2024

2007: 12009: 12010: 22011: 22012: 12013: 12014: 12015: 22016: 42018: 12019: 42020: 12022: 12023: 12024: 22026 (partial year): 1
2007high 4 (2016) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CDZ

141in 2019

2016: 276 days median2019: 141 days median
2007high 276 (2016) · low 141 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CDZ

1in 2025

2010: 12013: 12018: 12022: 12024: 12025: 12026 (partial year): 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CDZ

17in 2025

2007: 62008: 32009: 12010: 12011: 192012: 92013: 72014: 102015: 72016: 52017: 122018: 52019: 32020: 122021: 72022: 32023: 102024: 112025: 17
2007high 19 (2011) · low 1 (2009)2025

MAUDE reports naming product code CDZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—06
20080—03
20091—01
20102—11
20112—019
20121—09
20131—17
20141—010
20152—07
2016427605
20170—012
20181—15
2019414103
20201—012
20210—07
20221—13
20231—010
20242—111
20250—117
20261—1—

What is it indicated for?

The IMMULITE/IMMULITE 1000 Total Testosterone is for in vitro diagnostic use with the IMMULITE and IMMULITE 1000 Analyzers - for the quantitative measurement of testosterone in serum and plasma, as an aid in the diagnosis and management of conditions involving excess or deficiency of this androgen.

The IMMULITE 2000 Total Testosterone is for in vitro diagnostic use with the IMMULITE 2000 Analyzer - for the quantitative measurement of total testosterone in serum and plasma, as an aid in the diagnosis and management of conditions involving excess or deficiency of this androgen.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K032881: Immulite/Immulite 1000 Total Testosterone and Immulite 2000 Total Testosterone.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K032881

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026